Free Trial

Evoke (LON:EVOK) Trading Up 13% After Analyst Upgrade

Evoke logo with Consumer Cyclical background

Shares of Evoke plc (LON:EVOK - Get Free Report) rose 13% during mid-day trading on Tuesday after Berenberg Bank raised their price target on the stock from GBX 90 to GBX 95. Berenberg Bank currently has a buy rating on the stock. Evoke traded as high as GBX 70.30 ($0.95) and last traded at GBX 69.50 ($0.94). Approximately 5,723,622 shares were traded during trading, an increase of 175% from the average daily volume of 2,082,184 shares. The stock had previously closed at GBX 61.50 ($0.83).

Separately, JPMorgan Chase & Co. increased their price target on Evoke from GBX 77 ($1.04) to GBX 80 ($1.08) and gave the stock a "neutral" rating in a research note on Thursday, July 10th.

View Our Latest Stock Analysis on Evoke

Insider Activity

In related news, insider Per Widerström acquired 68,958 shares of the stock in a transaction dated Friday, May 23rd. The shares were acquired at an average price of GBX 54 ($0.73) per share, with a total value of £37,237.32 ($50,341.11). Also, insider Sean Wilkins acquired 31,659 shares of the firm's stock in a transaction dated Friday, May 23rd. The shares were purchased at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,095.86 ($23,111.88). Over the last three months, insiders purchased 202,269 shares of company stock valued at $10,515,918. Company insiders own 27.00% of the company's stock.

Evoke Stock Up 13.0%

The company has a market capitalization of £309.96 million, a P/E ratio of -1.74 and a beta of 0.84. The firm has a fifty day simple moving average of GBX 58.67 and a 200-day simple moving average of GBX 60.04.

About Evoke

(Get Free Report)

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines